Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps

Published:2018-03-29 Issue:2 Volume:39 Page:139-144
ISSN:0889-7077
Container-title:Substance Abuse
language:en
Short-container-title:Substance Abuse

Author:

Wyse Jessica J.¹,Gordon Adam J.²³,Dobscha Steven K.¹⁴,Morasco Benjamin J.¹⁴,Tiffany Elizabeth¹⁴,Drexler Karen⁵⁶⁷,Sandbrink Friedhelm⁸⁹¹⁰,Lovejoy Travis I.¹⁴

Affiliation:

1. VA Portland Health Care System, Portland, OR

2. VA Salt Lake City Health Care System, Salt Lake City, Utah

3. University of Utah, Salt Lake City, Utah

4. Oregon Health Science University, Portland, OR

5. Atlanta VA Medical Center, Decatur, GA

6. Office of Mental Health and Suicide Prevention, Veterans Health Administration, Washington DC

7. Emory University School of Medicine

8. VA Medical Center Washington DC

9. Specialty Care Services, Veterans Health Administration, Washington DC

10. George Washington University, Washington DC

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/08897077.2018.1452327

Reference33 articles.

1. Implementation of buprenorphine in the Veterans Health Administration: Results of the first 3 years

2. Accidental Poisoning Mortality Among Patients in the Department of Veterans Affairs Health System

3. Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths

4. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study;Journal of Substance Use and Addiction Treatment;2024-11

2. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV;AIDS and Behavior;2024-09-12

3. Engaging healthcare teams to increase access to medications for opioid use disorder;Health Services Research;2024-09-08

4. Sexually Transmitted Infection (STI) Incidence, STI Screening, and Human Immunodeficiency Virus Preexposure Prophylaxis Uptake in United States Veterans With Opioid Use Disorder in Long Island, New York;Open Forum Infectious Diseases;2024-07-22

5. Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings;Journal of General Internal Medicine;2024-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3